Tetrahydroquinoline derivatives as opioid receptor antagonists

被引：8

作者：

Zhang, Cunyu ^{[1
]}

Westaway, Susan M. ^{[2
]}

Speake, Jason D. ^{[1
]}

Bishop, Michael J. ^{[1
]}

Goetz, Aaron S. ^{[3
]}

Carballo, Luz Helena ^{[3
]}

Hu, Mike ^{[4
]}

Epperly, Andrea H. ^{[4
]}

机构：

[1] GlaxoSmithKline, Dept Med Chem, Res Triangle Pk, NC 27709 USA

[2] GlaxoSmithKline, Immunoinflammat CEDD, Stevenage SG1 2NY, Herts, England

[3] GlaxoSmithKline, Mol Discovery Res, Screening & Compound Profiling, Res Triangle Pk, NC 27709 USA

[4] GlaxoSmithKline, Dept Drug Metab & Pharmacokinet, Res Triangle Pk, NC 27709 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 02期

关键词：

Tetrahydroquinoline; Opioid; Antagonist; NALOXONE; ANALOGS; RATS; FOOD;

D O I：

10.1016/j.bmcl.2010.12.010

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Opioid receptors play an important role in both behavioral and homeostatic functions. We herein report tetrahydroquinoline derivatives as opioid receptor antagonists. SAR studies led to the identification of the potent antagonist 2v, endowed with 1.58 nM (K-i) functional activity against the mu opioid receptor. DMPK data suggest that novel tetrahydroquinoline analogs may be advantageous in peripheral applications. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：670 / 676

页数：7

共 50 条

[1] Synthesis of tetrahydroquinoline derivatives as novel histamine H4 receptor antagonists
Cheung, Hoi-Kit
Clark, Alia H.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
[2] Tetrahydroquinoline derivatives as CRTH2 antagonists
Liu, Jiwen
Wang, Yingcai
Sun, Ying
Marshall, Derek
Miao, Shichang
Tonn, George
Anders, Penny
Tocker, Joel
Tang, H. Lucy
Medina, Julio
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (24) : 6840 - 6844
[3] Antitrichomonal activity of δ opioid receptor antagonists, 7-benzylidenenaltrexone derivatives
Kutsumura, Noriki
Koyama, Yasuaki
Nagumo, Yasuyuki
Nakajima, Ryo
Miyata, Yoshiyuki
Yamamoto, Naoshi
Saitoh, Tsuyoshi
Yoshida, Naoko
Iwata, Satoshi
Nagase, Hiroshi
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (16) : 4375 - 4383
[4] Enantiomerically pure tetrahydroquinoline derivatives as in vivo potent antagonists of the glycine binding site associated to the NMDA receptor
Di Fabio, R
Tranquillini, E
Bertani, B
Alvaro, G
Micheli, F
Sabbatini, F
Pizzi, MD
Pentassuglia, G
Pasquarello, A
Messeri, T
Donati, D
Ratti, E
Arban, R
Dal Forno, G
Reggiani, A
Barnaby, RJ
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (21) : 3863 - 3866
[5] Propionamide Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the Treatment of Pain
Garcia, Monica
Llorente, Virginia
Garriga, Lourdes
Christmann, Ute
Rodriguez-Escrich, Sergi
Virgili, Marina
Fernandez, Begona
Bordas, Magda
Ayet, Eva
Burgueno, Javier
Pujol, Marta
Dordal, Albert
Portillo-Salido, Enrique
Gris, Georgia
Miguel Vela, Jose
Almansa, Carmen
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (14) : 10139 - 10154
[6] Antagonists of the kappa opioid receptor
Urbano, Mariangela
Guerrero, Miguel
Rosen, Hugh
Roberts, Edward
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (09) : 2021 - 2032
[7] Development of κ Opioid Receptor Antagonists
Carroll, F. Ivy
Carlezon, William A., Jr.
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (06) : 2178 - 2195
[8] Design, synthesis and biological evaluation of aminobenzyloxyarylamide derivatives as selective κ opioid receptor antagonists
Wang, Junwei
Song, Qiao
Xu, Anhua
Bao, Yu
Xu, Yungen
Zhu, Qihua
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 130 : 15 - 25
[9] Transformation of μ-opioid receptor agonists into biologically potent μ-opioid receptor antagonists
Li, Tingyou
Jinsmaa, Yunden
Nedachi, Masahiro
Miyazaki, Anna
Tsuda, Yuko
Ambo, Akihiro
Sasaki, Yusuke
Bryant, Sharon D.
Marczak, Ewa
Li, Qiang
Swartzwelder, H. Scott
Lazarus, Lawrence H.
Okada, Yoshio
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (03) : 1237 - 1251
[10] Novel opioid peptides as kappa opioid receptor antagonists
Aldrich, JV
Wan, Q
Murray, TF
PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 616 - 618

← 1 2 3 4 5 →